Biogen Inc (BIIB)

Current ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Total current assets	US$ in thousands	6,859,300	8,454,100	10,431,700	9,762,500	9,791,200	9,765,800	9,740,900	7,915,900	7,856,500	7,162,300	7,183,700	6,719,500	6,887,100	7,843,100	8,493,800	8,007,200	8,381,800	8,448,200	7,909,800	8,942,600
Total current liabilities	US$ in thousands	3,434,300	5,022,300	3,186,500	3,014,900	3,272,800	3,926,400	5,018,000	3,946,600	4,298,200	4,211,600	3,347,200	3,165,800	3,742,200	3,804,000	3,447,100	4,638,600	4,863,800	4,432,200	3,210,900	3,148,700
Current ratio		2.00	1.68	3.27	3.24	2.99	2.49	1.94	2.01	1.83	1.70	2.15	2.12	1.84	2.06	2.46	1.73	1.72	1.91	2.46	2.84

December 31, 2023 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $6,859,300K ÷ $3,434,300K
= 2.00

Biogen Inc's current ratio has displayed varying trends over the past eight quarters. In Q4 2023, the current ratio stood at 2.00, indicating that the company had $2.00 in current assets for each $1.00 in current liabilities. This represents an improvement from the previous quarter, where the current ratio was 1.68.

Looking further back, there was a significant increase in the current ratio in Q2 2023 and Q1 2023, with ratios of 3.27 and 3.24, respectively. This suggests that the company had a comfortable cushion of current assets to cover its short-term obligations during that period.

Comparing the current ratio in Q4 2023 to the same period in the previous year (Q4 2022), we see a slight increase from 2.99 to 2.00, indicating improved liquidity position. However, it is essential to note that the current ratio fluctuated throughout the quarters, possibly due to changes in the company's current assets and liabilities.

In conclusion, while the current ratio of Biogen Inc has shown fluctuations over the past eight quarters, the recent improvement in Q4 2023 suggests a stronger liquidity position compared to the previous quarter. It will be important to continue monitoring the company's current ratio to assess its ability to meet short-term obligations effectively.